78 related articles for article (PubMed ID: 6520478)
1. [Isolation and purification of placental coagulation inhibitor].
Shidara Y
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2583-92. PubMed ID: 6520478
[TBL] [Abstract][Full Text] [Related]
2. [Acting point of placental coagulation inhibitor].
Shidara Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):1-8. PubMed ID: 3973428
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a new anticoagulant protein, PP27, from placenta.
Chang GT; Oh JY; Choi EY; Chung KH; Kim JH; Kim CH
Thromb Res; 2005; 116(5):421-9. PubMed ID: 16122555
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of placental plasminogen activator (PPA).
Kobayashi T; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
[TBL] [Abstract][Full Text] [Related]
5. [Studies on a platelet aggregation inhibitor isolated from the human placenta].
Mochizuki O
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1729-36. PubMed ID: 3123574
[TBL] [Abstract][Full Text] [Related]
6. [Isolation of calphobindin-II and its mechanism of anticoagulant activity].
Kume K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1537-44. PubMed ID: 2531190
[TBL] [Abstract][Full Text] [Related]
7. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of platelet aggregation and blood coagulation isolated from the human placenta.
Maki M; Murata M; Shidara Y
Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):149-54. PubMed ID: 6734885
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
Farias WR; Nazareth RA; Mourão PA
Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
[TBL] [Abstract][Full Text] [Related]
10. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
[TBL] [Abstract][Full Text] [Related]
11. Haemostatic changes in pregnancy.
Brenner B
Thromb Res; 2004; 114(5-6):409-14. PubMed ID: 15507271
[TBL] [Abstract][Full Text] [Related]
12. Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential.
Zhang L; Wang J; Yu M; Ru B
Mol Genet Metab; 2004 Aug; 82(4):304-11. PubMed ID: 15308128
[TBL] [Abstract][Full Text] [Related]
13. [Human placental oxytocin and its increase by prostaglandin E2 and F2 alpha].
Sugahara M; Makino T; Nakazawa K; Motoyama S; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):287-92. PubMed ID: 2732562
[TBL] [Abstract][Full Text] [Related]
14. Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.
Cipriani TR; Gracher AH; de Souza LM; Fonseca RJ; Belmiro CL; Gorin PA; Sassaki GL; Iacomini M
Thromb Haemost; 2009 May; 101(5):860-6. PubMed ID: 19404539
[TBL] [Abstract][Full Text] [Related]
15. Boophilus microplus: its saliva contains microphilin, a small thrombin inhibitor.
Ciprandi A; de Oliveira SK; Masuda A; Horn F; Termignoni C
Exp Parasitol; 2006 Sep; 114(1):40-6. PubMed ID: 16600217
[TBL] [Abstract][Full Text] [Related]
16. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
[TBL] [Abstract][Full Text] [Related]
18. Procoagulant and anticoagulant mechanisms in human placenta.
Lanir N; Aharon A; Brenner B
Semin Thromb Hemost; 2003 Apr; 29(2):175-84. PubMed ID: 12709921
[TBL] [Abstract][Full Text] [Related]
19. Tissue anticoagulants in the human placenta: preliminary study with a heparin-like anticoagulant and review of the literature.
Uszyński M
Gynecol Obstet Invest; 1991; 32(3):129-33. PubMed ID: 1836773
[TBL] [Abstract][Full Text] [Related]
20. A novel anticoagulant protein from Scapharca broughtonii.
Jung WK; Je JY; Kim HJ; Kim SK
J Biochem Mol Biol; 2002 Mar; 35(2):199-205. PubMed ID: 12297030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
